Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis

被引：0
|
作者：
Fenghua Gao
Tingting Zhang
Hengqi Liu
Wei Li
Xianming Liu
Lihua Qiu
Lanfang Li
Shiyong Zhou
Zhengzi Qian
Sitong Dong
Sai Zhao
Xianhuo Wang
Huilai Zhang
机构：
[1] the Sino-US Center for Lymphoma and Leukemia Research,Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin’s Clinical Researc
[2] The Ingenuity Centre,Systematic Review Solutions Ltd
来源：
Annals of Hematology | 2022年 / 101卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2817 / 2817
相关论文
共 50 条
  • [41] Correction to: Prevalence and risk factors of sexual dysfunction in patients with inflammatory bowel disease: systematic review and meta‑analysis
    Jinzhi Zhang
    Shi Wei
    Qishan Zeng
    Xinyao Wu
    Huatian Gan
    International Journal of Colorectal Disease, 2021, 36 : 2039 - 2039
  • [42] Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials
    Vidal, Liat
    Gafter-Gvili, Anat
    Leibovici, Leonard
    Dreyling, Martin
    Ghielmini, Michele
    Schmitz, Shu-Fang Hsu
    Cohen, Amos
    Shpilberg, Ofer
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (04): : 248 - 255
  • [43] Validation of FLIPI1, FLIPI2, PRIMA and POD24 in Patients with Extranodal Follicular Lymphoma: A Cohort from Two Cancer Centers in Peru
    Vasquez, Jule F.
    Diaz, Alonso
    Mendoza, Any S.
    Barrionuevo, Carlos
    Samanez-Figari, Cesar
    BLOOD, 2021, 138
  • [44] CONFIRMATION OF THE IMPACT OF PRONOSTIC EVIL FACTORS (POD24, RC30) ON THE SURVIVAL OF PATIENTS WITH FOLICULAR LYMPHOMA. STUDY OF A SINGLE CENTER
    Donato Martin, E.
    Legarda Campo, M.
    Rubio Lopes-Garcia, L.
    Jimenez Castillo, M.
    Frances Aracil, E.
    Fernandez Zarzoso, M.
    Sayas Lloris, M. J.
    Ribas Garcia, P.
    Juan Marco, M. L.
    Fernandez Llavador, M. J.
    Marco Buades, J. E.
    Tolosa Munoz, A.
    Gimeno Brosel, M.
    Garcia Feria, A.
    Gomez Beltran, E.
    Ivars Santacreu, D.
    Moret Peiro, G.
    Valero Montoro, M.
    De la Rubia Comos, J.
    HAEMATOLOGICA, 2019, 104 : 157 - 157
  • [45] CVP plus rituximab compared to CVP alone in previously untreated patients with follicular lymphoma:: Impact of baseline prognostic factors
    Imrie, K
    Belch, A
    Pettengell, R
    Rueda, A
    McKendrick, J
    Solal-Céligny, P
    Offner, F
    Bence-Buckler, I
    Walewski, J
    Raposo, J
    Marcus, R
    ANNALS OF ONCOLOGY, 2005, 16 : 109 - 110
  • [46] Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis
    Simone Lanini
    Aoife C Molloy
    Paul E Fine
    Archibald G Prentice
    Giuseppe Ippolito
    Christopher C Kibbler
    BMC Medicine, 9
  • [47] Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis
    Lanini, Simone
    Molloy, Aoife C.
    Fine, Paul E.
    Prentice, Archibald G.
    Ippolito, Giuseppe
    Kibbler, Christopher C.
    BMC MEDICINE, 2011, 9
  • [48] Risk of inhibitors in previously untreated patients with hemophilia: a meta-analysis of literature studies
    Di Minno, Matteo Nicola Dario
    Marchesini, Emanuela
    Valdre, Lelia
    BLOOD, 2015, 125 (24) : 3819 - +
  • [49] Risk factors for patients with tracheal stenosis: a systematic review and meta-analysis
    Hong, Siqi
    Wu, Xiaobing
    Feng, Haihuan
    Zhang, Qing
    Wang, Xiaohan
    Chang, Minmin
    Chen, Xiuli
    Liu, Weijuan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (09)
  • [50] Risk Factors for Survival in Patients With Medulloblastoma: A Systematic Review and Meta-Analysis
    Liu, Yu
    Xiao, Bo
    Li, Sen
    Liu, Jiangang
    FRONTIERS IN ONCOLOGY, 2022, 12
12345